New York, NY -- (SBWIRE) -- 09/28/2013 -- StockMarketIntel.com issues a special report on the following stocks: AK Steel Holding Corporation (NYSE:AKS), MAKO Surgical Corp.(NASDAQ:MAKO), Amarin Corporation plc (ADR)(NASDAQ:AMRN), Halozyme Therapeutics, Inc.(NASDAQ:HALO)
AK Steel Holding Corporation (NYSE:AKS) declined -2.79% recently, while trading on 6.69 million shares at the price of $3.83. If we look at its trading history of the past 52 weeks, the share price suffered a low of $2.76 and was moved to its maximum level of $5.90.The stock changed hands in a range of $3.75 to $3.93, bringing its market capitalization at about $522.1 million. AK Steel Holding Corporation produces flat-rolled carbon, stainless and electrical steel, and tubular products in the United States and internationally.
Will AKS Continue To Move Higher? Find Out Here
MAKO Surgical Corp.(NASDAQ:MAKO) recently declined -0.07%, while trading on 6.61 million shares at the price of $29.48. If we look at its trading history of the past 52 weeks, the share price suffered a low of $10.00 and was moved to its maximum level of $29.59.The stock changed hands in a range of $29.44 to $29.56, bringing its market capitalization at about $1.39 billion. MAKO Surgical Corp., a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally.
Has MAKO Found The Bottom and Ready To Move Up? Find Out Here
Amarin Corporation plc (ADR)(NASDAQ:AMRN) declined -0.46% recently, in the current trading session, at $6.55 with a total volume of 6.39 million shares. The stock, on average, trades on a volume of 4.62 million shares. It floated in a range of $6.54 to $7.00 during the recent trading session, with a beta value of 1.30. Its market capitalization now moved to about $1.13 billion. In the past 52 weeks, the share price has not declined below $5.12 or above $12.96. Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases
Has AMRN Found The Bottom And Ready To Gain Momentum? Find Out Here
Halozyme Therapeutics, Inc.(NASDAQ:HALO) recently added +6.91% and was moving within a range of $10.58-$12.15, its current trading price is $11.30. The stock is moving up till now with a total volume of 6.33 million shares, versus an average volume of 1.62 million shares. The share price hit its 52-week low of $4.80 and $12S.15 was the best price. Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human enzymes.
Where HALO is Headed Exactly? Find out in This Trend Analysis Reports
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)